T1	Lab 0 2	WD
T2	Disease_disorder 9 77	a 45-year-old, single male with a diagnosis of chronic schizophrenia
T3	Quantitative_concept 24 30	single
T4	Sign_symptom 31 35	male
T5	Disease_disorder 43 52	diagnosis
T6	Disease_disorder 56 77	chronic schizophrenia
T7	Disease_disorder 64 77	schizophrenia
T8	Quantitative_concept 131 135	unit
T9	Qualitative_concept 155 159	well
T10	Sign_symptom 168 174	normal
T11	Sign_symptom 168 196	normal metabolic functioning
T12	Lab 175 184	metabolic
T13	Lab 198 200	WD
T14	Qualitative_concept 210 216	stable
T15	Medication 220 242	clozapine for 10 years
T16	Disease_disorder 234 236	10
T17	Quantitative_concept 249 252	one
T18	Disease_disorder 249 305	one significant relapse in 2012 following self-cessation
T19	Qualitative_concept 253 264	significant
T20	Disease_disorder 265 272	relapse
T21	Activity 291 305	self-cessation
T22	Disease_disorder 324 333	catatonia
T23	Procedure 339 383	required emergency electroconvulsive therapy
T24	Disease_disorder 348 357	emergency
T25	Procedure 348 383	emergency electroconvulsive therapy
T26	Procedure 358 383	electroconvulsive therapy
T27	Procedure 376 383	therapy
T28	Procedure 385 388	ECT
T29	Quantitative_concept 399 411	re-titration
T30	Medication 399 424	re-titration of clozapine
T31	Medication 415 424	clozapine
T32	Qualitative_concept 448 456	February
T33	Disease_disorder 465 474	catatonic
T34	Sign_symptom 479 521	the context of self-cessation of clozapine
T35	Sign_symptom 483 490	context
T36	Activity 494 508	self-cessation
T37	Medication 512 521	clozapine
T38	Sign_symptom 528 544	his mental state
T39	Sign_symptom 532 544	mental state
T40	Sign_symptom 565 572	periods
T41	Sign_symptom 565 585	periods of agitation
T42	Sign_symptom 576 585	agitation
T43	Disease_disorder 590 596	mutism
T44	Medication 621 645	intramuscular olanzapine
T45	Medication 635 645	olanzapine
T46	Medication 651 673	zuclopenthixol acetate
T47	Medication 651 665	zuclopenthixol
T48	Medication 666 673	acetate
T49	Qualitative_concept 675 677	WD
T50	Qualitative_concept 688 692	well
T51	Procedure 696 699	ECT
T52	Qualitative_concept 704 709	total
T53	Activity 723 731	sessions
T54	Qualitative_concept 744 751	initial
T55	Disease_disorder 752 773	phase of his recovery
T56	Disease_disorder 814 835	neuroleptic malignant
T57	Disease_disorder 814 844	neuroleptic malignant syndrome
T58	Disease_disorder 836 844	syndrome
T59	Lab 853 864	temperature
T60	Medication 869 875	?C, cr
T61	Procedure 869 871	?C
T62	Disease_disorder 869 872	?C,
T63	Medication 869 877	?C, crea
T64	Lab 1036 1045	patient's
T65	Procedure 1043 1059	's course of ECT
T66	Procedure 1056 1059	ECT
T67	Medication 1061 1070	clozapine
T68	Medication 1061 1080	clozapine titration
T69	Diagnostic_procedure 1071 1080	titration
T70	Activity 1085 1094	commenced
T71	Disease_disorder 1103 1108	fast'
T72	Sign_symptom 1103 1107	fast
T73	Lab 1126 1130	WD's
T74	Sign_symptom 1126 1156	WD's baseline cardiac function
T75	Lab 1131 1139	baseline
T76	Sign_symptom 1140 1156	cardiac function
T77	Anatomical_structure 1140 1147	cardiac
T78	Qualitative_concept 1168 1174	normal
T79	Sign_symptom 1181 1219	his left ventricular ejection fraction
T80	Sign_symptom 1185 1219	left ventricular ejection fraction
T81	Sign_symptom 1202 1210	ejection
T82	Qualitative_concept 1239 1247	measured
T83	Lab 1277 1285	Baseline
T84	Lab 1286 1301	cardiac enzymes
T85	Anatomical_structure 1286 1293	cardiac
T86	Qualitative_concept 1312 1318	normal
T87	Procedure 1320 1330	Troponin I
T88	Disease_disorder 1333 1337	0.03
T89	Quantitative_concept 1338 1343	ug/l;
T90	Lab 1344 1346	CK
T91	Quantitative_concept 1351 1355	iu/l
T92	Qualitative_concept 1367 1371	full
T93	Diagnostic_procedure 1372 1389	blood examination
T94	Anatomical_structure 1372 1377	blood
T95	Disease_disorder 1400 1417	electrocardiogram
T96	Procedure 1419 1422	ECG
T97	Lab 1425 1443	C-reactive protein
T98	Procedure 1436 1443	protein
T99	Procedure 1445 1448	CRP
T100	Quantitative_concept 1454 1461	22 mg/l
T101	Quantitative_concept 1457 1461	mg/l
T102	Medication 1463 1485	The same day clozapine
T103	Qualitative_concept 1467 1471	same
T104	Medication 1476 1485	clozapine
T105	Activity 1490 1499	commenced
T106	Activity 1508 1518	discovered
T107	Lab 1524 1526	WD
T108	Disease_disorder 1536 1545	suffering
T109	Disease_disorder 1551 1574	an ischiorectal abscess
T110	Disease_disorder 1554 1574	ischiorectal abscess
T111	Disease_disorder 1567 1574	abscess
T112	Lab 1591 1602	antibiotics
T113	Lab 1604 1618	flucloxacillin
T114	Sign_symptom 1604 1631	flucloxacillin 1g QID IV/PO
T115	Quantitative_concept 1633 1637	14/7
T116	Procedure 1657 1665	incision
T117	Procedure 1670 1678	drainage
T118	Disease_disorder 1687 1720	no symptoms of systemic infection
T119	Sign_symptom 1690 1698	symptoms
T120	Disease_disorder 1702 1720	systemic infection
T121	Disease_disorder 1711 1720	infection
T122	Disease_disorder 1729 1737	afebrile
T123	Quantitative_concept 1745 1750	times
T124	Lab 1762 1764	th
T125	Medication 1770 1814	coinciding with Day 4 of clozapine titration
T126	Disease_disorder 1786 1791	Day 4
T127	Disease_disorder 1790 1791	4
T128	Medication 1795 1804	clozapine
T129	Diagnostic_procedure 1805 1814	titration
T130	Procedure 1817 1824	his CRP
T131	Lab 1821 1824	CRP
T132	Procedure 1829 1858	180 mg/l and white cell count
T133	Quantitative_concept 1833 1837	mg/l
T134	Procedure 1842 1858	white cell count
T135	Anatomical_structure 1842 1852	white cell
T136	Procedure 1848 1858	cell count
T137	Anatomical_structure 1848 1852	cell
T138	Procedure 1882 1896	Blood cultures
T139	Procedure 1882 1905	Blood cultures that day
T140	Anatomical_structure 1882 1887	Blood
T141	Procedure 1888 1896	cultures
T142	Qualitative_concept 1911 1919	negative
T143	Procedure 1925 1959	both CRP and WCC normalised 2 days
T144	Lab 1930 1933	CRP
T145	Diagnostic_procedure 1938 1941	WCC
T146	Activity 1983 1987	Save
T147	Qualitative_concept 1991 1998	initial
T148	Disease_disorder 2016 2028	asymptomatic
T149	Sign_symptom 2029 2040	tachycardia
T150	Quantitative_concept 2042 2049	100-130
T151	Lab 2056 2058	WD
T152	Medication 2068 2113	his clozapine target dose of 400 mg by Day 20
T153	Lab 2072 2093	clozapine target dose
T154	Medication 2072 2081	clozapine
T155	Diagnostic_procedure 2082 2088	target
T156	Procedure 2101 2103	mg
T157	Disease_disorder 2111 2113	20
T158	Sign_symptom 2123 2136	further issue
T159	Sign_symptom 2131 2136	issue
T160	Medication 2145 2168	the clozapine titration
T161	Medication 2149 2158	clozapine
T162	Diagnostic_procedure 2159 2168	titration
T163	Lab 2193 2195	to
T164	Disease_disorder 2208 2223	agranulocytosis
T165	Qualitative_concept 2244 2256	unremarkable
T166	Disease_disorder 2269 2274	Day 4
T167	Procedure 2280 2304	Day 22 a troponin and CK
T168	Lab 2324 2332	troponin
T169	Procedure 2342 2348	the CK
T170	Quantitative_concept 2354 2359	found
T171	Lab 2360 2362	to
T172	Qualitative_concept 2366 2374	elevated
T173	Lab 2376 2386	Troponin I
T174	Lab 2385 2391	I 0.65
T175	Disease_disorder 2387 2391	0.65
T176	Quantitative_concept 2392 2396	ug/l
T177	Procedure 2410 2412	CK
T178	Quantitative_concept 2410 2420	CK 53 iu/l
T179	Quantitative_concept 2416 2420	iu/l
T180	Lab 2422 2423	N
T181	Disease_disorder 2426 2432	60-285
T182	Lab 2447 2454	opinion
T183	Medication 2482 2495	the clozapine
T184	Medication 2486 2495	clozapine
T185	Qualitative_concept 2500 2506	ceased
T186	Procedure 2508 2543	The following day an echocardiogram
T187	Diagnostic_procedure 2529 2543	echocardiogram
T188	Qualitative_concept 2559 2568	worsening
T189	Lab 2581 2589	function
T190	Qualitative_concept 2596 2600	July
T191	Lab 2612 2616	LVEF
T192	Activity 2624 2631	dropped
T193	Disease_disorder 2658 2665	falling
T194	Lab 2666 2675	troponins
T195	Disease_disorder 2677 2681	0.33
T196	Quantitative_concept 2696 2700	ug/l
T197	Procedure 2706 2746	nonelevation of CRP over the next 2 days
T198	Lab 2722 2725	CRP
T199	Qualitative_concept 2748 2752	lack
T200	Sign_symptom 2748 2780	lack of past or current symptoms
T201	Sign_symptom 2772 2780	symptoms
T202	Lab 2809 2811	WD
T203	Qualitative_concept 2821 2827	stable
T204	Medication 2831 2840	clozapine
T205	Medication 2831 2853	clozapine for 10 years
T206	Disease_disorder 2845 2847	10
T207	Lab 2875 2879	felt
T208	Qualitative_concept 2890 2898	clinical
T209	Qualitative_concept 2911 2919	unlikely
T210	Lab 2920 2922	to
T211	Activity 2923 2932	represent
T212	Disease_disorder 2933 2944	myocarditis
T213	Medication 2946 2955	Clozapine
T214	Qualitative_concept 2995 3002	slower'
T215	Medication 3003 3012	clozapine
T216	Diagnostic_procedure 3013 3022	titration
T217	Disease_disorder 3023 3031	protocol
T218	Diagnostic_procedure 3038 3049	cardiac MRI
T219	Anatomical_structure 3038 3045	cardiac
T220	Procedure 3046 3049	MRI
T221	Lab 3100 3102	WD
T222	Disease_disorder 3113 3117	ECGs
T223	Disease_disorder 3119 3123	CRPs
T224	Lab 3128 3137	troponins
T225	Qualitative_concept 3154 3160	normal
T226	Disease_disorder 3191 3196	Day 4
T227	Quantitative_concept 3200 3212	re-titration
T228	Disease_disorder 3226 3238	asymptomatic
T229	Medication 3247 3256	clozapine
T230	Quantitative_concept 3261 3272	re-titrated
T231	Qualitative_concept 3274 3276	WD
T232	Procedure 3292 3308	olanzapine 10 mg
T233	Medication 3292 3302	olanzapine
T234	Procedure 3306 3308	mg
T235	Lab 3309 3312	tds
T236	Quantitative_concept 3324 3327	2.5
T237	Medication 3324 3342	2.5 mg perindopril
T238	Quantitative_concept 3328 3330	mg
T239	Medication 3331 3342	perindopril
T240	Disease_disorder 3361 3366	Day 7
T241	Medication 3361 3392	Day 7 of clozapine re-titration
T242	Diagnostic_procedure 3380 3392	re-titration
T243	Qualitative_concept 3406 3410	well
T244	Disease_disorder 3423 3448	no signs of heart failure
T245	Sign_symptom 3426 3431	signs
T246	Disease_disorder 3435 3448	heart failure
T247	Anatomical_structure 3435 3440	heart
T248	Disease_disorder 3480 3488	afebrile
T249	Quantitative_concept 3496 3501	times
T250	Procedure 3512 3553	the planned cardiac MRI the following day
T251	Diagnostic_procedure 3524 3535	cardiac MRI
T252	Anatomical_structure 3524 3531	cardiac
T253	Procedure 3532 3535	MRI
T254	Procedure 3561 3606	a significant global reduction in LVEF of 38%
T255	Qualitative_concept 3563 3574	significant
T256	Qualitative_concept 3575 3581	global
T257	Procedure 3582 3599	reduction in LVEF
T258	Procedure 3582 3591	reduction
T259	Disease_disorder 3608 3639	plus regional myocardial oedema
T260	Disease_disorder 3613 3639	regional myocardial oedema
T261	Anatomical_structure 3622 3632	myocardial
T262	Disease_disorder 3633 3639	oedema
T263	Qualitative_concept 3644 3651	delayed
T264	Procedure 3644 3683	delayed gadolinium contrast enhancement
T265	Lab 3652 3662	gadolinium
T266	Qualitative_concept 3663 3671	contrast
T267	Procedure 3672 3683	enhancement
T268	Disease_disorder 3698 3725	recent or acute myocarditis
T269	Disease_disorder 3708 3725	acute myocarditis
T270	Disease_disorder 3714 3725	myocarditis
T271	Medication 3728 3737	Clozapine
T272	Qualitative_concept 3759 3765	ceased
T273	Lab 3767 3769	WD
T274	Quantitative_concept 3782 3793	re-titrated
T275	Procedure 3800 3810	25 mg mane
T276	Quantitative_concept 3803 3817	mg mane/ 75 mg
T277	Procedure 3803 3805	mg
T278	Anatomical_structure 3806 3811	mane/
T279	Anatomical_structure 3806 3810	mane
T280	Procedure 3812 3837	75 mg nocte by this point
T281	Quantitative_concept 3832 3837	point
T282	Disease_disorder 3843 3847	1.25
T283	Medication 3843 3861	1.25 mg bisoprolol
T284	Lab 3848 3850	mg
T285	Medication 3851 3861	bisoprolol
T286	Lab 3878 3882	WD's
T287	Sign_symptom 3878 3901	WD's mental state sadly
T288	Sign_symptom 3883 3895	mental state
T289	Disease_disorder 3908 3920	deteriorated
T290	Procedure 3936 3947	further ECT
T291	Procedure 3944 3947	ECT
T292	Procedure 3952 3971	combination therapy
T293	Procedure 3952 3985	combination therapy of olanzapine
T294	Procedure 3964 3971	therapy
T295	Medication 3975 3985	olanzapine
T296	Lab 3987 3998	haloperidol
T297	Medication 4000 4010	sertraline
T298	Medication 4015 4022	lithium
T299	Lab 4023 4025	to
T300	Qualitative_concept 4026 4032	return
T301	Sign_symptom 4033 4065	him to his baseline mental state
T302	Sign_symptom 4044 4065	baseline mental state
T303	Lab 4044 4052	baseline
T304	Lab 4053 4059	mental
T305	Sign_symptom 4076 4096	his cardiac function
T306	Sign_symptom 4080 4096	cardiac function
T307	Anatomical_structure 4080 4087	cardiac
T308	Qualitative_concept 4097 4105	improved
T309	Medication 4112 4121	clozapine
T310	Medication 4112 4131	clozapine cessation
T311	Activity 4122 4131	cessation
T312	Procedure 4138 4172	a follow-up echocardiogram 8 weeks
T313	Sign_symptom 4140 4149	follow-up
T314	Diagnostic_procedure 4150 4164	echocardiogram
T315	Lab 4196 4200	LVEF
T316	Disease_disorder 4204 4210	45-50%
T317	Lab 4212 4222	A 10-month
T318	Procedure 4212 4246	A 10-month comparative cardiac MRI
T319	Diagnostic_procedure 4235 4246	cardiac MRI
T320	Anatomical_structure 4235 4242	cardiac
T321	Procedure 4243 4246	MRI
T322	Qualitative_concept 4248 4253	ruled
T323	Qualitative_concept 4254 4257	out
T324	Disease_disorder 4258 4311	ischaemic injury as a cause of the elevated troponins
T325	Disease_disorder 4268 4288	injury as a cause of
T326	Disease_disorder 4268 4274	injury
T327	Qualitative_concept 4293 4301	elevated
T328	Lab 4302 4311	troponins
T329	Qualitative_concept 4313 4320	minimal
T330	Lab 4321 4332	wall motion
T331	Disease_disorder 4333 4346	abnormalities
T332	Qualitative_concept 4369 4375	global
T333	Disease_disorder 4369 4402	global resolution of inflammation
T334	Disease_disorder 4376 4386	resolution
T335	Disease_disorder 4390 4402	inflammation
T336	Lab 4407 4409	LV
T337	Lab 4410 4418	function
T338	Lab 4420 4424	LVEF
T339	Quantitative_concept 4441 4445	most
T340	Disease_disorder 4460 4480	previous myocarditis
T341	Disease_disorder 4469 4480	myocarditis
